Synucleinopathies trials recruiting in Minnesota

Fewer than 3 recruiting trials found.

All Synucleinopathies trials nationally

1

Recruiting in Minnesota

2

Cities with sites

Cities in Minnesota

Golden Valley 1Rochester 1

Recruiting trials in Minnesota

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
NCT07589595 · Phase: Phase 2 · Ages: 55 Years to 85 Years · Sex: All (male and female) · Minnesota: Golden Valley, Rochester

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.